TPG

TPG is a publicly traded global alternative asset management firm that invests across private equity, impact, credit, real estate, and market solutions. While it is not itself a biotech, pharma, or healthcare operating company, it has a large and longstanding healthcare investment franchise through platforms including TPG Healthcare Partners and TPG Life Sciences Innovations. Its healthcare investing spans pharma and biotech, medical devices, diagnostics, healthcare services, and tech-enabled healthcare businesses. TPG has backed or owned a range of healthcare companies such as Allogene, AskBio, Adare, Novotech, Precision for Medicine, and OneOncology. For a biotech analyst, TPG is best understood as an influential healthcare-focused financial sponsor rather than a drug developer with an internal therapeutic pipeline.